Connection
David Orlicky to Xenograft Model Antitumor Assays
This is a "connection" page, showing publications David Orlicky has written about Xenograft Model Antitumor Assays.
|
|
Connection Strength |
|
|
|
|
|
0.039 |
|
|
|
-
Dhar D, Raina K, Kumar D, Wempe MF, Bagby SM, Pitts TM, Orlicky DJ, Agarwal C, Messersmith WA, Agarwal R. Bitter melon juice intake with gemcitabine intervention circumvents resistance to gemcitabine in pancreatic patient-derived xenograft tumors. Mol Carcinog. 2020 10; 59(10):1227-1240.
Score: 0.039